Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             36 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs Alba, E.

3 1 p. 31-35
artikel
2 Book review de Tribolet, N.

3 1 p. 40
artikel
3 Book review Sessa, C.

3 1 p. 58
artikel
4 Book review Pedrazzini, A.

3 1 p. 44
artikel
5 Book reviews Bosia, C.

3 1 p. 70
artikel
6 Chronological age is a multifactorial prognostic variable in patients with Non-Hodgkin’s Lymphoma Ansell, S.M.

3 1 p. 45-50
artikel
7 Clinical cancer research: Cancer treatment from the ‘Red Baron’ Dresden Dickman, Steven

3 1 p. 2-4
artikel
8 Contents of the next issue
3 1 p. 1
artikel
9 Copyright
3 1 p. iv
artikel
10 Cyclophosphamide, Adriamycin and Cisplatin (CAP) versus Cyclophosphamide, Adriamycin and Vincristin (CAV) in the treatment of advanced ovarian cancer: A randomized study Krommer, C.F.

3 1 p. 37-39
artikel
11 Does extra height justify a higher risk of breast cancer? Stoll, B.A.

3 1 p. 29-30
artikel
12 Editorial board
3 1 p. iv
artikel
13 ESMO Award Lecture coupled with Oliva Prize
3 1 p. 6
artikel
14 Europeans still undecided on chemoprevention for breast cancer
3 1 p. 5-6
artikel
15 Expression of MDR1 and GST-π in human soft tissue sarcomas: Relation to drug resistance and biological aggressiveness Toffoli, G.

3 1 p. 63-69
artikel
16 Extramedullary plasmacytoma: Clinical behaviour and response to treatment Soesan, M.

3 1 p. 51-57
artikel
17 First Horten Prize to Doll and Peto
3 1 p. 2
artikel
18 Free enterprise, nurses and ethical problems in Maastricht
3 1 p. 4-5
artikel
19 Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor Damstrup, L.

3 1 p. 71-77
artikel
20 Instructions to Authors
3 1 p. 89-90
artikel
21 In this issue
3 1 p. 1
artikel
22 Is interferon-a an active agent in Castleman’s disease? Pavlidis, N.A.

3 1 p. 85-86
artikel
23 Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach Vokes, E.E.

3 1 p. 79-81
artikel
24 Patient treatment on a compassionate basis: Documentation of high adverse drug reaction rate Leyland-Jones, B.

3 1 p. 59-62
artikel
25 Perhaps not everyone knows that…
3 1 p. 6-7
artikel
26 Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer Weinerman, B.

3 1 p. 83-84
artikel
27 Randomized clinical trial with a weekly regimen of 5-FU vs 5-FU + intermediate-dose folinic acid in the treatment of advanced colo-rectal cancer Martoni, A.

3 1 p. 87-88
artikel
28 Recognition of tumor-associated antigens by T lymphocytes: From basic concepts to new approaches Cerottini, J.-C.

3 1 p. 11-16
artikel
29 Sanctuary site relapse in chemotherapy-treated testicular cancer James, P.P.B.

3 1 p. 41-43
artikel
30 Table of Contents
3 1 p. v-vi
artikel
31 The Annals continues to grow Cavalli, F.

3 1 p. 8
artikel
32 Title Page
3 1 p. iii
artikel
33 Treatment of advanced ovarian cancer: 10 years of experience Neijt, J.P.

3 1 p. 17-27
artikel
34 Underground production of cytotoxic drugs?
3 1 p. 6
artikel
35 Very high endothelin plasma levels in patients with 5-FU cardiotoxicity Thyss, A.

3 1 p. 87-88
artikel
36 Ways to a better treatment of small cell lung cancer—a commentary Østerlind, K.

3 1 p. 9-10
artikel
                             36 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland